Healthcare provider profile · identity verified

Robert H Gordon, MD

Geriatric Medicine · NORTH WALES, PA · NPI 1710901673

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	660	19
Gabapentin	Gabapentin	561	15
Omeprazole	Omeprazole	371	11
Amlodipine Besylate	Amlodipine Besylate	357	16
Duloxetine Hcl	Duloxetine Hcl	296	suppressed
Furosemide	Furosemide	281	15
Mirtazapine	Mirtazapine	274	suppressed
Lisinopril	Lisinopril	256	suppressed
Levothyroxine Sodium	Levothyroxine Sodium	252	suppressed
Eliquis	Apixaban	231	suppressed
Potassium Chloride	Potassium Chloride	219	11
Metformin Hcl	Metformin Hcl	216	suppressed
Losartan Potassium	Losartan Potassium	208	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	208	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	172	suppressed
Trazodone Hcl	Trazodone Hcl	168	11
Donepezil Hcl	Donepezil Hcl	165	suppressed
Divalproex Sodium	Divalproex Sodium	161	suppressed
Metoprolol Succinate	Metoprolol Succinate	154	suppressed
Clopidogrel	Clopidogrel Bisulfate	153	suppressed
Finasteride	Finasteride	143	suppressed
Methenamine Hippurate	Methenamine Hippurate	136	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	132	suppressed
Paroxetine Hcl	Paroxetine Hcl	130	suppressed
Myrbetriq	Mirabegron	129	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	126	suppressed
Simvastatin	Simvastatin	119	suppressed
Warfarin Sodium	Warfarin Sodium	119	suppressed
Famotidine	Famotidine	117	suppressed
Digoxin	Digoxin	115	suppressed
Midodrine Hcl	Midodrine Hcl	110	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	108	suppressed
Ropinirole Hcl	Ropinirole Hcl	106	suppressed
Verapamil Er	Verapamil Hcl	103	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	102	suppressed
Glipizide	Glipizide	95	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	87	suppressed
Clonazepam	Clonazepam	86	suppressed
Prednisone	Prednisone	80	suppressed
Aripiprazole	Aripiprazole	75	suppressed
Gemtesa	Vibegron	72	suppressed
Tradjenta	Linagliptin	72	suppressed
Lovastatin	Lovastatin	70	suppressed
Hydralazine Hcl	Hydralazine Hcl	65	suppressed
Bumetanide	Bumetanide	63	suppressed
Pravastatin Sodium	Pravastatin Sodium	63	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	62	suppressed
Saxagliptin Hcl	Saxagliptin Hcl	57	suppressed
Baclofen	Baclofen	55	suppressed
Nifedipine Er	Nifedipine	55	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	54	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	54	suppressed
Allopurinol	Allopurinol	53	suppressed
Haloperidol	Haloperidol	53	suppressed
Indapamide	Indapamide	53	suppressed
Raloxifene Hcl	Raloxifene Hcl	53	suppressed
Tramadol Hcl	Tramadol Hcl	53	13
Xarelto	Rivaroxaban	53	suppressed
Sertraline Hcl	Sertraline Hcl	51	suppressed
Diltiazem Hcl	Diltiazem Hcl	49	suppressed
Memantine Hcl	Memantine Hcl	49	suppressed
Divalproex Sodium Er	Divalproex Sodium	46	suppressed
Dutasteride	Dutasteride	43	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	43	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	40	suppressed
Oxycodone Hcl	Oxycodone Hcl	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	37	suppressed
Azathioprine	Azathioprine	35	suppressed
Clozapine	Clozapine	34	suppressed
Morphine Sulfate Er	Morphine Sulfate	34	suppressed
Prasugrel Hcl	Prasugrel Hcl	34	suppressed
Primidone	Primidone	34	suppressed
Carvedilol	Carvedilol	33	suppressed
Silodosin	Silodosin	33	suppressed
Topiramate	Topiramate	31	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	29	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Calcium Acetate	Calcium Acetate	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Latanoprost	Latanoprost	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Ondansetron Hcl	Ondansetron Hcl	23	15
Livalo	Pitavastatin Calcium	22	suppressed
Fluticasone Propionate	Fluticasone Propionate	20	suppressed
Montelukast Sodium	Montelukast Sodium	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	18	suppressed
Ketoconazole	Ketoconazole	18	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	13
Humalog	Insulin Lispro	17	suppressed
Novolog Flexpen	Insulin Aspart	17	suppressed
Diazepam	Diazepam	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Rytary	Carbidopa/Levodopa	16	suppressed
Valsartan	Valsartan	16	suppressed
Atenolol	Atenolol	15	suppressed
Fiasp Flextouch	Insulin Aspart (Niacinamide)	15	suppressed
Lorazepam	Lorazepam	15	suppressed
Repatha Syringe	Evolocumab	15	suppressed
Ammonium Lactate	Ammonium Lactate	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Timolol Maleate	Timolol Maleate	13	suppressed
Aimovig Autoinjector	Erenumab-Aooe	12	suppressed
Alprazolam	Alprazolam	12	suppressed
Amiodarone Hcl	Amiodarone Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Nystop	Nystatin	12	suppressed
Vancomycin Hcl	Vancomycin/Water For Inj (Peg)	12	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Levofloxacin	Levofloxacin	11	11
Paxlovid	Nirmatrelvir/Ritonavir	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error